主要目的:评价SHR-1701联合吉西他滨和白蛋白紫杉醇一线治疗晚期/转移性胰腺癌患者的安全性和有效性次要目的:评价SHR-1701的药代动力学(PK)属性;9个月生存率(OS rates at 9-month);通过其他疗效指标来评价SHR-1701联合吉西他滨和白蛋白紫杉醇一线治疗晚期/转移性胰腺癌患者的有效性;探索性目的:评价SHR-1701的免...
The age-related changes as well as the strain and sex differences in each measured item were examined. The body weight of each strain increased, but rate of the increase was less in SHR and SHRSP, and was lowest in SHRSP. 展开 被引量: 86 年份: 2004 ...